Considering the high association with PD-1 and other immune checkpoints, the overlap and diverse interaction between various immune checkpoints may attenuate the prognostic impact of PD-1 in ESCC (Supplementary Table 10). This evidence concerns the gene PDCD1 and esophageal squamous cell carcinoma.